Inspira Technologies Oxy BHN ( ($IINN) ) has issued an update. On November 13, 2025, Inspira Technologies announced the completion of a clinical ...

Inspira Technologies OXY B.H.N. Ltd. IINN recently announced plans to report clinical results for its new HYLA blood sensor in open-heart surgery patients. Since the medical industry is highly ...

Since embarking on a focused strategy to grow HYLA, Endexx has been committed to strengthening its market presence both domestically and internationally. Recent efforts have culminated in significant ...

Inspira announced results for its HYLA blood sensor, achieving 97.35% accuracy in its latest performance testing phase that will support its upcoming U.S. Food and Drug Administration submission.

Inspira Technologies (NASDAQ:IINN) announced, on Tuesday, positive results from the clinical study of its AI-powered HYLA blood sensor. The company reported that the HYLA successfully achieved 96% ...

Endexx acquired the controlling interest (51%) of Hyla USA Holdco Limited. Endexx grew from 4,000 Mass Retail stores to over 8,000. Endexx garnered top 2 selling CBD pain products in Mass Retail ...